Related resources and publications
VISTA - safety and PK profiling
Humanized VISTA mouse & Pharmacokinetics
Humanized ICP mouse and cell lines
Humanized PD-1/PD-L1 mouse and cell line
Nat Commun
Front Immunol
J Allergy Clin Immunol
J Immunother Cancer
Nat Cancer
![](https://cdn.prod.website-files.com/655dd3c88278aa64954052d4/667bc7144a5476f0864a459c_cidara_poster_AACR2024_PD-1-PD-L1_website.webp)
Multispecific CD73/PD-1 targeting
![](https://cdn.prod.website-files.com/655dd3c88278aa64954052d4/667be0695ce2a262f3472a0d_bonum_poster_AACR2024_PD-1-Lag3_website_preview.webp)
Safety and Activity of a Conditionally Active cLAG3-IL2
![](https://cdn.prod.website-files.com/655dd3c88278aa64954052d4/667c207d23d5d174996bc454_anaveon-poster-sitc2023-pd-1_preview.webp)
Novel PD-1 targeted IL-2Rβ/γ agonist
![](https://cdn.prod.website-files.com/655dd3c88278aa64954052d4/667c0c7b11d209e44467ad5d_anaveon-poster-aacr2023-pd-1_preview.jpg)
PD-1 & strong tumor growth inhibition
![](https://cdn.prod.website-files.com/655dd3c88278aa64954052d4/667c133e6fa6f3bbb37a20e1_reaction-biology-poster-aacr2023-pd-1_preview.webp)
hPD-1 to evaluate novel cancer therapies
![](https://cdn.prod.website-files.com/655dd3c88278aa64954052d4/65829fd6c3d918f937e6169d_img-poster-sensei-2022.jpg)
BRGSF-HIS & hVISTA for immunotherapies
![](https://cdn.prod.website-files.com/655dd3c88278aa64954052d4/667d20fcd65d09a0a98304f8_sensei_poster_AACR2022_vista-brgsf-his_preview.webp)
VISTA in the tumor microenvironment
![](https://cdn.prod.website-files.com/655dd3c88278aa64954052d4/667d2985911fb201833add06_kineta-poster-aacr2021-vista_preview.webp)
anti-hVISTA against poorly immunogenic tumors